Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure
Phase 2
Completed
- Conditions
- Heart Failure, Congestive
- Registration Number
- NCT00202579
- Lead Sponsor
- Institut de Recherches Internationales Servier
- Brief Summary
To evaluate the effects on heart function of ivabradine administered to patients with severe chronic heart failure
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
- systolic congestive heart failure
- sinus rhythm, HR >= 80bpm
Read More
Exclusion Criteria
- unstable cardiovascular condition
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Systolic and diastolic blood pressure Haemodynamic parameters Twelve-lead ECG
- Secondary Outcome Measures
Name Time Method Neurohormones Echocardiography
Trial Locations
- Locations (1)
Policlinico San Matteo
🇮🇹Pavia, Italy